During the past decade, UCL Institute of Neurology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCL Institute of Neurology" #1 sponsor was "University College, London" with 8 trials, followed by "Alexion" with 1 trials sponsored, "Ataxia Study Group" with 1 trials sponsored, "Biogen" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCL Institute of Neurology" #1 collaborator was "Medical Research Council" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator, "Clinical Trials Research Unit, University of Sheffield" with 1 trials as a collaborator and "Dystonia Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "UCL Institute of Neurology" are "Multiple Sclerosis" (4 trials), "Aphasia" (2 trials), "Brain Injuries" (2 trials), "Parkinson's Disease" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "UCL Institute of Neurology" in a lesser frequency.

Most popular intervention types in "UCL Institute of Neurology" are "Drug" (6 trials), "Device" (4 trials), "Procedure" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anticholinergic medication" (1 trials), "BG00012" (1 trials), "Behavioural study" (1 trials), "Bilateral GPi Deep Brain Stimulation" (1 trials) and "Bilateral Nucleus Basalis Meynert DBS" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCL Institute of Neurology" are 19 trials for "All" genders.

Currently, there are NaN active trials in "UCL Institute of Neurology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in UCL Institute of Neurology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in UCL Institute of Neurology, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".